
Redox Biology Publication: CB3 Peptide Regulates Oxidative Stress and Neuroinflammation, Emerging as a New Hope for Durable Antiepileptic Effects
Today, we share important research led by Tawfeeq Shekh-Ahmad's team from the Hebrew University of Jerusalem, published in Redox Biology. This study is the first to systematically evaluate the therapeutic potential of the thioredoxin-mimetic peptide TXM-CB3 (CB3) in a temporal lobe epilepsy model. The research found that CB3 can significantly delay epileptogenesis, reduce spontaneous recurrent seizures (SRS) during the chronic phase, and improve epilepsy-associated cognitive dysfunction by modulating key pathways of oxidative stress and neuroinflammation. Notably, CB3 maintained durable antiepileptic effects even after treatment cessation, demonstrating true disease-modifying therapy characteristics. This offers new hope for approximately 30-40% of patients with drug-resistant epilepsy.

From Chlorella to Oral Liquid: Development and Application Prospects of High-Value Bioactive Peptides

Application of Peptide Synthesis in Metal Ion Detection

Microbial Fermentation for the Production of Rapeseed Protein Peptides

Review of Advances in Analgesic Peptide Molecules

A Review of Antibacterial Peptides Against Bacterial Biofilms

A Review of the Sources, Mechanisms of Action, and Application Prospects of Antioxidant Peptides

A Review of Peptide Applications in Influenza Virus Research

Review of the Preparation and Applications of Chemically Synthesized Peptide Antibodies


